KEGG   PATHWAY: ray05213
Entry
ray05213                    Pathway                                
Name
Endometrial cancer - Rousettus aegyptiacus (Egyptian rousette)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
ray05213  Endometrial cancer
ray05213

Disease
H00026  Endometrial cancer
Organism
Rousettus aegyptiacus (Egyptian rousette) [GN:ray]
Gene
107497091  BAD; bcl2-associated agonist of cell death [KO:K02158]
107497434  KRAS; GTPase KRas isoform X1 [KO:K07827]
107497830  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
107498193  EGFR; epidermal growth factor receptor isoform X1 [KO:K04361] [EC:2.7.10.1]
107498395  AKT1; RAC-alpha serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
107498704  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X1 [KO:K02649]
107498762  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
107498831  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
107499083  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
107499343  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
107499602  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
107499847  NRAS; LOW QUALITY PROTEIN: GTPase NRas [KO:K07828]
107500934  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
107501760  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X2 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
107501830  CASP9; caspase-9 [KO:K04399] [EC:3.4.22.62]
107503391  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
107503781  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
107504052  BRAF; serine/threonine-protein kinase B-raf isoform X2 [KO:K04365] [EC:2.7.11.1]
107504363  ILK; integrin-linked protein kinase isoform X1 [KO:K06272] [EC:2.7.11.1]
107506131  AXIN1; axin-1 isoform X1 [KO:K02157]
107506202  MYC; myc proto-oncogene protein [KO:K04377]
107506285  TCF7L1; transcription factor 7-like 1 [KO:K04490]
107506450  POLK; DNA polymerase kappa isoform X1 [KO:K03511] [EC:2.7.7.7]
107506797  TCF7; transcription factor 7 isoform X1 [KO:K02620]
107507127  HRAS; GTPase HRas isoform X1 [KO:K02833]
107508819  EGF; pro-epidermal growth factor isoform X1 [KO:K04357]
107508942  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 isoform X1 [KO:K04368] [EC:2.7.12.2]
107509353  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
107509357  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
107510301  AXIN2; axin-2 isoform X1 [KO:K04385]
107510357  CTNNA3; catenin alpha-3 [KO:K05691]
107510634  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
107511436  SOS2; son of sevenless homolog 2 [KO:K03099]
107511497  LEF1; lymphoid enhancer-binding factor 1 isoform X1 [KO:K04492]
107511705  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
107511851  DDB2; DNA damage-binding protein 2 [KO:K10140]
107511968  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
107512008  APC; adenomatous polyposis coli protein isoform X1 [KO:K02085]
107513958  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
107513978  AKT3; RAC-gamma serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
107514682  CDKN1A; cyclin-dependent kinase inhibitor 1 [KO:K06625]
107515689  TP53; cellular tumor antigen p53 isoform X1 [KO:K04451]
107515836  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
107517741  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
107517828  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
107517899  [KO:K02649]
107518480  FOXO3; forkhead box protein O3 [KO:K09408]
107518703  CTNNA1; catenin alpha-1 [KO:K05691]
107519446  SOS1; son of sevenless homolog 1 isoform X1 [KO:K03099]
107519729  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X1 [KO:K04366] [EC:2.7.11.1]
107519993  CTNNB1; catenin beta-1 [KO:K02105]
107520147  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
107520152  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
107520573  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha [KO:K04402]
107520648  CDH1; cadherin-1 isoform X2 [KO:K05689]
107520699  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
107521668  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta isoform X1 [KO:K02649]
107521783  AKT2; RAC-beta serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
ray04010  MAPK signaling pathway
ray04012  ErbB signaling pathway
ray04060  Cytokine-cytokine receptor interaction
ray04110  Cell cycle
ray04115  p53 signaling pathway
ray04151  PI3K-Akt signaling pathway
ray04310  Wnt signaling pathway
ray04520  Adherens junction
KO pathway
ko05213   

DBGET integrated database retrieval system